Description

Overview

Lyme disease is a bacterial infection caused by Borrelia burgdorferi, transmitted through the bite of an infected blacklegged (deer) tick. Unlike antibody-based testing, PCR testing detects the actual genetic material (DNA) of the Lyme bacteria, providing direct evidence of infection.

PCR testing is particularly useful in early infection, certain persistent or atypical cases, and in patients who may not yet have mounted a detectable antibody response.

What This Test Measures

The Lyme Disease PCR test identifies Borrelia burgdorferi DNA in the bloodstream using highly sensitive molecular amplification techniques.

  • Detects active infection, not immune response
  • Not dependent on antibody production
  • Useful when ELISA or antibody testing is negative but suspicion remains high

Clinical Significance

PCR testing may be especially helpful in:

  • Early-stage Lyme disease before antibodies develop
  • Immunocompromised patients with reduced antibody response
  • Patients with persistent or recurrent symptoms
  • Cases with unclear or conflicting serologic results

A positive PCR result indicates the presence of bacterial DNA and supports an active or recent infection.

A negative result does not fully exclude Lyme disease, as bacterial DNA may be intermittently present or localized in tissues rather than circulating in blood.

Symptoms That May Prompt Testing

  • Bull’s-eye or expanding rash (erythema migrans)
  • Fever, headache, fatigue, and flu-like symptoms
  • Migratory joint, muscle, tendon, or bone pain
  • Stiff neck
  • Neurologic symptoms such as nerve pain, tingling, or cognitive changes
  • Heart palpitations, irregular heartbeat, dizziness
  • Unexplained chronic fatigue or inflammatory symptoms following tick exposure

Who Should Consider Lyme PCR Testing

  • Patients with recent tick exposure and early symptoms
  • Individuals with high clinical suspicion but negative antibody tests
  • Patients with ongoing symptoms after prior treatment
  • Individuals living in or traveling to Lyme-endemic regions
  • Patients with suspected neurologic or cardiac Lyme involvement

Important Notes & Limitations

  • PCR detects bacterial DNA, not antibody response
  • A negative result does not definitively rule out Lyme disease
  • Sensitivity may vary depending on stage of infection and specimen type
  • Results should be interpreted alongside clinical history and exposure risk
  • PCR testing may be used alone or in combination with antibody-based testing